Global /China /Healthcare /Drug Manufacturers - General /002349

Jinghua Pharmaceutical Group Co., Ltd.

002349

• SHE: 002349 • Delayed

7.52CNY 2.9%

1.11 USD

As of 15 June 2026, Jinghua Pharmaceutical Group Co., Ltd. has a market cap of $895.06M USD, ranking #11351 globally and #3274 in China. It ranks #1024 in the Healthcare sector, and #384 in the Drug Manufacturers - General industry.

Global Rank

11351

Country Rank

3274

Sector Rank

1024

Industry Rank

384

Key Stats

Market Cap

$895.06MUSD

6.06B CNY

Enterprise Value

$764.71MUSD

5.18B CNY

Revenue (TTM)

$215.46MUSD

1.46B CNY

EBITDA (TTM)

$53.71MUSD

363.51M CNY

Net Income (TTM)

$32.36MUSD

219.28M CNY

EBITDA Margin

25%

Profit Margin

15%

PE Ratio

27.3

PS Ratio

4.2

PB Ratio

1.9

EV/EBITDA

14.1

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Jian Cheng open_in_new

Employees

1,490

Founded

1957

Website

jinghuapharm.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2.9%	4.2%	3.6%	-1.2%	1.1%	3.6%	8.8%	-30%	59%

News

Markets

Exchange	Ticker	Price	Quotes
Shenzhen Stock Exchange (SHE / SZSE) MIC: XSHE PRIMARY	002349 精华制药集团股份有限公司 Class A ISIN: CNE100000L14 Shares Out.: Shares Outstanding: 814.181M¹ Shares Float: 496.927M² TV: TradingView: SZSE: 002349 SA: Stock Analysis: SHE: 002349 YF: Yahoo Finance: 002349.SZ GF: Google Finance: SHE: 002349 BA: Barron's: 002349 MS: Morningstar: XSHE: 002349	7.52 CNY	TV: TradingView: SZSE: 002349 SA: Stock Analysis: SHE: 002349 YF: Yahoo Finance: 002349.SZ GF: Google Finance: SHE: 002349 BA: Barron's: 002349 MS: Morningstar: XSHE: 002349

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Jinghua Pharmaceutical Group Co., Ltd.

Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenobarbital, Primidone, Fluorouracil, Phenylbutazone, Flucytosine, Piroxicam, and Propylthiouracil APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. The company was founded in 1957 and is based in Nantong, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 6K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 5K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 3K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 2K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 2K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 2K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 85K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 61K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 40K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 36K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 32K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 31K%	20.5	Switzerland

chevron_leftBack